Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
25.87
+1.20 (4.86%)
At close: Jun 26, 2026, 4:00 PM EDT
26.99
+1.12 (4.33%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Zenas BioPharma Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Zenas BioPharma stock have an average target of 43.67, with a low estimate of 22 and a high estimate of 55. The average target predicts an increase of 68.81% from the current stock price of 25.87.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Zenas BioPharma stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $44 | Buy | Reiterates | $44 | +70.08% | Jun 8, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $55 | Buy | Maintains | $55 | +112.60% | Jun 5, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $21 → $22 | Hold | Maintains | $21 → $22 | -14.96% | May 14, 2026 |
| Wedbush | Wedbush | Buy Maintains $45 | Buy | Maintains | $45 | +73.95% | May 14, 2026 |
| Citi | Citi | Buy Reiterates $41 | Buy | Reiterates | $41 | +58.48% | May 14, 2026 |
Financial Forecast
Revenue This Year
36.26M
from 10.00M
Increased by 262.60%
Revenue Next Year
63.25M
from 36.26M
Increased by 74.43%
EPS This Year
-4.33
from -4.83
EPS Next Year
-2.27
from -4.33
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 75.0M | 95.8M | |
| Avg | 36.3M | 63.2M | |
| Low | n/a | 23.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 650.0% | 164.1% | |
| Avg | 262.6% | 74.4% | |
| Low | -100.0% | -35.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -4.33 | -2.27 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.